Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) EPS (Weighted Average and Diluted): 2022-2025

Historic EPS (Weighted Average and Diluted) for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to -$3.36.

  • Praxis Precision Medicines' EPS (Weighted Average and Diluted) fell 22.18% to -$3.36 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.96, marking a year-over-year decrease of 39.50%. This contributed to the annual value of -$10.21 for FY2024, which is 45.37% up from last year.
  • Latest data reveals that Praxis Precision Medicines reported EPS (Weighted Average and Diluted) of -$3.36 as of Q3 2025, which was down 1.51% from -$3.31 recorded in Q2 2025.
  • Praxis Precision Medicines' EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.96 during Q3 2022, with a 5-year trough of -$65.86 in Q4 2022.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$3.00 (2024), whereas its average is -$3.90.
  • The largest annual percentage gain for Praxis Precision Medicines' EPS (Weighted Average and Diluted) in the last 5 years was 97.02% (2023), contrasted with its biggest fall of 600.66% (2023).
  • Quarterly analysis of 4 years shows Praxis Precision Medicines' EPS (Weighted Average and Diluted) stood at -$65.86 in 2022, then soared by 97.02% to -$1.96 in 2023, then crashed by 53.06% to -$3.00 in 2024, then dropped by 22.18% to -$3.36 in 2025.
  • Its EPS (Weighted Average and Diluted) was -$3.36 in Q3 2025, compared to -$3.31 in Q2 2025 and -$3.29 in Q1 2025.